FLCN antibody | knockout validation | Abcam ab124885

This is a knockout-validated antibody summary, based on the publications "The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue" (shown below) [1] and "Myeloid Folliculin balances mTOR activation to maintain innate immunity homeostasis" (see figure 1a, western blot) [2]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

FLCN antibody | knockout validation | Abcam ab124885 figure 1
Figure 1. Western blot showing the efficiency of FLCN protein deletion in BAT and iWAT in FLCN adipKO compared to WT. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: FLCN

Catalog number: ab124885

Summary: Rabbit monoclonal IgG against a recombinant tagged protein fragment corresponding to human FLCN. Reacts with mouse, rat, and human by western blot. Unsuitable for flow cytometry ,immunocytochemistry, immunohistochemistry (paraffin) or immunoprecipitation.

Validation Method

Western blot

Sample

BAT and iWAT from WT and adipose tissue-specific deletion of FLCN. Tissue or cell samples were lysed by RIPA buffer containing phosphatase inhibitor (PhosSTOP, Roche) and proteinase inhibitor (Complete miniproteinase inhibitor cocktail, Roche).

Blocking agent

5% skim milk for 1 h.

Secondary incubation

HRP-conjugated secondary antibodies.

Detection

Digital imager (GE Healthcare Life Sciences, ImageQuant LAS 4000).

References
  1. Wada S, Neinast M, Jang C, Ibrahim Y, Lee G, Babu A, et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 2016;30:2551-2564 pubmed
  2. Li J, Wada S, Weaver L, Biswas C, Behrens E, Arany Z. Myeloid Folliculin balances mTOR activation to maintain innate immunity homeostasis. JCI Insight. 2019;5: pubmed publisher